Philip Mease is a Spondyloarthritis Studies and Treatments physician. OpenAlex indexes 1,793 publications with 85,511 citations (h-index 124); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Rheumatology profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Philip Mease, MD, is profiled from the public federal record. The public record shows 1,793 publications with 85,511 citations (h-index 124), centered on Spondyloarthritis Studies and Treatments, Psoriasis: Treatment and Pathogenesis, Rheumatoid Arthritis Research and Therapies. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 49 companies.
- Most recent indexed publication: 2026 · Rheumatology (Oxford, England)
- Top research focus: Spondyloarthritis Studies and Treatments
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 49 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 202 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 568.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Clinical and Molecular Characterization of Axial Psoriatic Arthritis (PsA), A Pilot Study
Sponsor: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis
Industry payments
Updated 18 Oct 2026
49 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- UCB, Inc.Program year202552 payments$52,808openpaymentsdata.cms.gov ↗
- Lilly USA, LLCProgram year202525 payments$50,413openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202545 payments$37,304openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
92%TNF inhibitor81.8%Certolizumab pegol52%Golimumab48%Part B, office-administered≥35 patientsSelective T Cell Costimulation Modulator10.2%Abatacept99%Orencia1%Part D + Part B<11 patientsMusculoskeletal
8%RANK Ligand Inhibitor8%Denosumab100%Part B, office-administered≥24 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Bimekizumab efficacy across GRAPPA domains to 3 years in patients with psoriatic arthritis: a post hoc analysis of two phase 3 studies.
Rheumatology (Oxford, England)
Article2026 - Who Achieves Minimal and Very Low Disease Activity in Psoriatic Arthritis? An Analysis of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
The Journal of rheumatology
Article2026 - Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial.
Arthritis & rheumatology (Hoboken, N.J.)
Clinical Trial2026
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03
- 04
- 052016 Revisions to the 2010/2011 fibromyalgia diagnostic criteriaArticle2,220 citations2016
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Other
providence.elsevierpure.com/en/persons/philip-mease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providence.elsevierpure.com ↗ - Other
swedish.org/doctors/rheumatology/wa/seattle/philip-mease-1336218171
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →swedish.org ↗
Mentions by others
where others cite or feature them- Other
psoriasiscouncil.org/people/philip-mease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psoriasiscouncil.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →swedish.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →swedish.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →swedish.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →swedish.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →swedish.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →swedish.org ↗
Editorial & leadership roles
journal and society appointments- Past President and Founding Organizer
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asas-group.org ↗ - Past President
Northwest Rheumatism Society
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asas-group.org ↗ - Co-Chair
PsA Task Force, National Psoriasis Foundation
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asas-group.org ↗ - Member
Assessment of Spondyloarthritis International Society (ASAS)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asas-group.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asas-group.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →newswise.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →asas-group.org ↗
Secondary affiliations
appointments beyond the home institution- Clinical Professor
University of Washington School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asas-group.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →swedish.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cm.healio.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pharmacytimes.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →psoriasis.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Dinesh Khanna, MD
University of Michigan